slides · global inventory
Turn
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 37,461
Current window 17,341-17,370
Pages 1,249
Rows per page 30
Beat
17,341-17,370 of 37,461
14
Uses a 'vs' comparison framework to contrast Aeva's continuous wave approach against pulsed legacy systems.Aeva | Investor Presentation Deck | 33 slides · Aeva
Pitch deck Investor relations Beat · Solution1 hit
15
The slide uses a hub-and-spoke visual metaphor to show how various proprietary technologies converge into a single chip.Aeva | Investor Presentation Deck | 33 slides · Aeva
Pitch deck Investor relations Beat · Solution1 hit
14
Uses a comparison frame to establish technical superiority.Aeva | SPAC Presentation Deck | 36 slides · Aeva
Pitch deck Investment bank Beat · Solution1 hit
15
The slide uses a hub-and-spoke visual layout to connect the Aeva brand to its six core technological pillars.Aeva | SPAC Presentation Deck | 36 slides · Aeva
Pitch deck Investment bank Beat · Solution1 hit
16
The slide uses a three-column layout to detail specific software performance metrics.Aeva | SPAC Presentation Deck | 36 slides · Aeva
Pitch deck Investment bank Beat · Solution1 hit
07
Includes flags of participating countries, trial flow diagram, and demographic breakdown.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
08
The slide uses color-coding to distinguish between regions with ongoing trials (light green) and those with regulatory submissions on a rolling basis (dark green).BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
09
The slide highlights significant supply commitments across multiple regions, with some financial and volume details withheld.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
10
The slide outlines a cold-chain logistics process for a pharmaceutical product.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
11
BioNTech | Results Presentation Deck | 25 slidesBioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
12
The slide uses a Gantt-style visualization for clinical trial phases.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
13
FIH = First in Human; PRT = Protein Replacement Therapy; 3 = We are eligible to receive worldwide licensesBioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
14
The slide illustrates the biological mechanism of a bispecific antibody targeting PD-L1 and 4-1BB.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
15
The slide uses a staircase diagram to represent dose escalation and a list for expansion cohorts.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
16
Data presented in a table format showing age, gender, cancer type, and prior treatment history.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
17
The chart uses a broken axis between 50 and 100.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
18
Data shows fold change from baseline for four different markers, comparing lower vs higher doses with statistical significance (p-values) indicated.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
19
Waterfall plot showing clinical trial efficacy data.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
20
Waterfall plot (A) and Spider plot (B) showing patient response data.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
06
The note at the bottom clarifies the reporting period for retail sales.Capri Holdings | Results Presentation Deck | 9 slides · Capri Holdings
Conference presentation Investor relations Beat · Satisfaction1 hit
07
Capri Holdings | Results Presentation Deck | 9 slidesCapri Holdings | Results Presentation Deck | 9 slides · Capri Holdings
Conference presentation Investor relations Beat · Satisfaction1 hit
08
Slide 8 of a presentation deck.Capri Holdings | Results Presentation Deck | 9 slides · Capri Holdings
Conference presentation Investor relations Beat · Satisfaction1 hit
07
The slide highlights technical capabilities and productivity metrics at the bottom.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
08
The slide uses a biological interaction map to demonstrate the breadth of the company's target library.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
09
The slide shows a workflow from a 'toolbox of validated leads' to 'high-throughput expression & characterization' and finally to specific multi-specific constructs.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
10
The slide uses a Gantt-style chart to show the progress of four distinct programs.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
11
The slide uses a timeline framework to track progress of four distinct programs (CTX-471 monotherapy, CTX-471 combo, CTX-8371, and NKp30 platform) plus future programs.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
12
Compass Therapeutics | IPO Presentation Deck | 40 slidesCompass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
13
The slide uses a molecular structure diagram to illustrate the binding site differences between CTX-471 and existing therapies.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
14
The slide uses a before-after-bridge style framing to highlight the drug's superior efficacy compared to standard monotherapies.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit